Ebola Virus
Ebola Virus
Hemorrhagic Fever
Outbreaks
Outbreaks
1976- First Major
Outbreak (ZEBOV)
1976- Sudan
(SEBOV)
Occur Sporadically
www.cdc.gov for
more information
Where does Ebola hide?
Where does Ebola hide?
2002- Fruit Bats
Antibodies against Ebola
Ebola Gene sequences in
liver and spleen
Fruit bats do not show
any symptoms
Best candidate to be the
reservoir
More research needs to
be done
Geography
Geography
The link between human infection by the Ebola virus
and their proximity to primates is clear.
-Outbreaks occurred in countries that house 80 percent
of the world’s remaining wild gorilla and chimpanzee
populations.
- The outbreaks coincided with the outbreaks in wild
animals.
- The same distinct viral strains were isolated in animal
carcasses and in the bodies of those who handled those
carcasses.
- These outbreaks were preceded by an abnormally
large death in wild Gorilla populations.
Clinical Observations
Clinical Observations
Incubation period: 2-21 days
Stage I (unspecific):
-Extreme asthenia (body weakness)
-diarrhea, nausea and vomiting, anorexia
abdominal pain
- headaches
- arthralgia (neuralgic pain in joints)
- myalgia (muscular pain or tenderness), back pain
- mucosal redness of the oral cavity, dysphagia (difficulty in
swallowing)
- conjunctivitis.
- rash all over body except in face
** If the patients don’t recover gradually at this point, there is a high
probability that the disease will progress to the second phase, resulting
in complications which eventually lead to death (Mupapa et al., 1999).
Stage II (Specific):
- Hemorrhage
- neuropsychiatric abnormalities
- anuria (the absence of urine formation)
- hiccups
- tachypnea (rapid breathing).
** Patients who progressed to phase two EHF almost always die.
(Ndambi et al., 1999)
Late Complications:
-Arthralgia
- ocular diseases (ocular pain, photophobia and hyperlacrimation)
- hearing loss
- unilateral orchitis( inflammation of one or both of the testes)
** These conditions are usually relieved with the treatment of 1%
atropine and steroids
Epidemiology
Epidemiology
Ebola Hemorrhagic Fever was first found in 1976
It struck two countries within that year
a. Sudan – in a town called N’zara
b. Zaire, now known as the Democratic Republic of
Congo
In these two instances the mortality rate was between
50 –90%
Following those epidemics, Ebola hit Africa in many
other instances the worst yet being in the year 2000
when it struck Uganda infecting more than 400 people.
Transmission
Transmission
contracted through contact of any infected individual’s body
fluids
Ebola HF prevention
poster used in Kikwit
outbreak.
Controlling the spread of Ebola
Controlling the spread of Ebola
a. Hospitals must follow precautionary methods, such
as:
1. wearing gloves
2. isolating infected individuals
3. practicing nurse barrier techniques
4. proper sterilization and disposal of all equipment
b. Burials must be done correctly
1. no washing or touching carcass
2. put into body bags and bury outside city
c. Report any questionable illness to officials
Ebola Subtypes
Ebola Subtypes
Ebola-Zaire
(ZEBOV)
Ebola-Sudan
(SEBOV)
Ebola Ivory-Coast
(ICEBOV)
Ebola-Reston
(REBOV)
MOLECULAR STRUCTURE
MOLECULAR STRUCTURE
Characterization of the virus
–
Order: Mononegavirales
–
Family: Filoviridae
–
Genus: Ebolavirus
–
Species: Ebola-Zaire, Ebola-Sudan, Ebola-Cote d-Ivoire, Ebola-Reston
Morphology under electron microscope
–
filamentous, enveloped RNA virus
–
approx. 19 kb in length (1 kb = 1000 RNA
bases/nucleotides) or 60-80 nm in diameter
–
single-stranded, linear, non-segmented
–
negative-sense RNA (encoded in a 3’ to 5’ direction)
–
appears to have “spikes” due to glycoprotein on
outside membrane
Structure of Ebola genome and proteins
–
Transcribed into 8 sub-genomic mRNA proteins: 7
structural and 1 nonstructural
–
7 structural proteins:
–
nucleoprotein (NP)
–
4 viral/virion proteins (VP35, VP40, VP30, VP24)
–
glycoprotein (GP)
–
RNA-dependent RNA polymerase (L protein)
•
NP, VP35, VP30, L protein: required for transcription &
replication
•
VP40, GP, VP24: associated with the membrane
Proteins
Proteins
Ethics
Ethics
Biogeograophical Ethics is defined as motivation
based on ideas of right and wrong when dealing
with the geographical distribution of animals and
plants.
This concept of can be used to explain the world’s
shockingly small response to the Ebola Virus.
Because there was little travel to that region by
people of more developed countries, there was not
much economic drive for a vaccine, treatment,
and aid in prevention.
Bioterrorism
Bioterrorism
Since the September 11 bombings in the
United States, the locality of this virus has
become less isolated as the threat of
bioterrorism looms large.
The Ebola virus is now on the “A” list for
hopeful vaccination development.
Experiments have even been formed to show
how Ebola can be used as a bioterror agent.